News Center

Home page

Peak Report

News reports

Spike with my growth for twenty years

Release time:

2020-08-14

Peak Accompanied My Growth for 20 Years

■ Xu Junxiong

, a pharmaceutical sales company, has been working for 20 years. Recall the bits and pieces of the past, only to find that the original time can carry all the memories, like a video disc, clearly recorded those sour or sweet moments, scene by scene, slowly presented in the brain. Memories of the past, taste the past, evoke some deep in the heart of the aftertaste. In the year of

, I graduated from the health school and went to the society. I was lucky to join Jianfeng Group, the largest and most famous enterprise in Jinhua. After a period of internship in the group clinic, the company arranged me to work in the infirmary of the cable company. "No, I'm the only one in the infirmary." I felt scared, can I do it well? can I do it well? "if you can do it well, just do it with your heart. if you don't understand something, you should ask more questions and consult more." Tang Huamei, head of the group's medical office, encouraged me to say. Although I was not sure, I decided to try hard, because from then on, I had a formal job and didn't have to ask for money from my family to support myself. I was an adult. After arriving at the cable company, I was responsible for the health management of more than 200 people in the whole factory. in addition to working hard, I also used the weekend break to study with the teachers in Jinhua hospital of traditional Chinese medicine. My efforts were recognized by my colleagues and quickly integrated into this big family.

years passed quickly, and I set myself a "great" goal: to take root in Jinhua and buy a two-bedroom apartment of 60 square meters! But the problem is that this goal is difficult to achieve if you rely on the death salary of the infirmary. Just at the beginning of 2001 , Jianfeng Pharmaceutical recruited salesmen for the company, "more work, more pay, no ceiling". I thought for a long time and finally made up my mind to make a dash. Through interviews and training, I successfully became a medical representative of the new special drug company.

To be honest, at that time I could say nothing but youth and passion. Fortunately, newborn calves are not afraid of tigers. As long as they lock in their customers, no matter how high the other party's position is, they will visit them first. Of course, it was always not smooth at first. I was well prepared. Facing the serious face of the other party, I was so nervous that I wanted to leave immediately. At such times, I secretly warn myself to be calm and calm. I am here to recommend good products. I will be turned away in a big deal. If I can't, I will find another department. Someone will always recognize you. This is repeated over and over again, coupled with the guidance of senior brothers and sisters, I slowly grew up, more and more customers recognized me and liked me, and my performance began to show. In those years, I used to be the first in the whole team in terms of sales volume of single hospital products and the first in the whole team in terms of sales volume generated by full coverage of single hospital products. It's hard to run business in the wind and rain, and stay away from my family. Of course, it's hard, but in the constant efforts, I grow up and mature. My house is spacious, my wife is beautiful, my children are lovely, and my happiness index can be imagined.

One day in August, 2011 9 , the leader suddenly talked to me and said that he was going to let me be the assistant to the general manager of Jianfeng Pharmaceutical Sales Company, responsible for the terminal sales in Zhejiang region. The news came so suddenly that I had never learned management and was at a loss. Can I do it? Can I do it? After consulting in many ways and thinking for three days and three nights, I finally made a decision to return to the company to take office.

The new position has new responsibilities, and the change of roles means that the problem must be considered more comprehensively and pay more attention to the overall situation, and the interests of team members must be taken into account while creating performance and profits. Because I have been in the marketing front line for many years, I know the hard work and ideas of the salesmen, as well as their difficulties and hopes for the company. I can think of others in management and strive for a win-win situation between the enterprise and the individual. Over the past few years, the general environment has been beset with difficulties, and the unit price of drug sales has been falling all the way. However, our terminal sales have been able to increase at a 25% rate every year, from no profit in 2012 to turning losses into profits, to an estimated profit of more than 3 million yuan this year.

Over the past 20 years, inspired by the enterprise spirit of "unity and struggle, truth-seeking and innovation, determination to rise to the top, and eternal climbing to the top", I have grown up under the care and care of leaders at all levels of the peak, and have made continuous progress with the support and help of all colleagues. In addition to serving as the executive deputy general manager of the pharmaceutical sales company, I have also obtained a licensed pharmacist certificate and become a member of Zhejiang Pharmaceutical Association, through the self-study examination to obtain a bachelor's degree in business management, self-worth has been continuously realized. Over the past 20 years, I have witnessed the growth of the peak year by year and the continuous record of performance. I am very proud to think that these achievements also have their own modest strength, and I am happy to work in such a company.

I grew up in the peak. The peak is wonderful because of the efforts of our peak people. I naturally blend with the peak and cannot be separated. As a peak person, I will continue to self-study, self-improvement, self-improvement, conscientious, excellence to do their job. I believe that with the unremitting struggle of all our peak people, the peak will move towards a higher development dimension and stand at the peak of the industry.

More information

Yunnan peak through the safety standard secondary acceptance

On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate

2020

07-30

Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory

News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Accident-free factory creation enters "second season"

At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open

2020

07-31

What will the Chinese Medicine Act bring us?

At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.

2020

07-31

< 1...49 50 51...61 > 跳转到页